Navigation Links
McMaster study contradicts reports of problems with blood-thinner
Date:8/29/2010

New findings by McMaster University researchers contradict earlier reports that people with a certain genetic make-up don't benefit from the blood-thinner clopidogrel, also known as Plavix.

After researchers from the United States, France and Germany reported clopidogrel is less effective in some patients, the Food and Drug Administration (FDA) in the United States issued a black box warning to physicians on the drug's package insert.

"(Our findings) add a further layer of complexity to the FDA 'black box' warning and show that reported genetic variants have no effect in certain patient populations," said Dr. Guillaume Par, lead researcher and assistant professor of pathology and molecular medicine at the Michael G. DeGroote School of Medicine.

Clopidogrel is the world's second best-selling prescription drug with global sales of more than $6 billion annually. It is used in 110 countries by millions of people to reduce the risk of heart attack and stroke.

Following the FDA's warning, clopidogrel became the focus of on-going debates within cardiology circles. Some American cardiologists initially called the FDA's actions irresponsible. Others complained they were left without any appropriate direction on how to manage their patients.

About 20 per cent of the population carry the loss-of-function version of the gene involved in the clopidogrel controversy.

To assess the influence genetics might have on patients prescribed clopidogrel, Par and colleagues from McMaster University conducted a genetic sub-study of 6,000 participants from two major clinical trials (CURE and ACTIVE). The CURE (Clopidogrel in Unstable Angina to Prevent Recurrent Ischemic Events) trial of 12,562 patients with acute coronary syndrome in 28 countries found clopidogrel significantly reduces the risk of heart attack stroke and dying. The ACTIVE (Atrial Fibrillation Clopidogrel Trial with Irbesartan for the Prevention of Vascular Events) tr
'/>"/>

Contact: Laura Thompson
lthomp@mcmaster.ca
905-525-9140
McMaster University
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. McMaster researcher leads development of promising drug for inflammation
2. Vaccine has cut child cases of bacterial pneumonia, says study
3. Even Before Recession, 14 Million Kids Underinsured: Study
4. Penn study sheds light on how the brain shifts between sleep/awake states under anesthesia
5. Study Links Gene to Serious Eye Disease
6. Study Suggests Statins Could Help Some With Normal Cholesterol
7. Heart Risks the Same With 2 Diabetes Drugs: Study
8. Mayo researchers develop new laboratory cell lines to study treatment for ATC
9. Herpes Drugs Wont Raise Birth Defect Risk, Study Finds
10. Mumps vaccine coverage should be improved, study finds
11. Study Suggests Link Between Diet Sodas, Preterm Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 23, 2013 Hile Design LLC is ... was awarded a Silver Creative Award at the Summit ... winning entry was for its “Open Doors” animation promoting ... Show” in the 2013 District 6 ADDY Awards for ... Summit Creative Award recognizes and celebrates the creative achievements ...
(Date:5/23/2013)... 2013 Fresh Healthy Vending is a ... with healthy food and drinks in locations such as ... full-service marketing and advertising department has a goal of ... for their franchisees, and to promote the Fresh Healthy ... in many leading publications and TV networks across the ...
(Date:5/23/2013)... May 23, 2013 Jim Fitzpatrick just ... Fitzpatrick Advertising developed yet another outside-of-the-box approach to reaching ... News.com, he brings daily newscasts to the retail automotive ... delivery of a broadcast news format. , CBTNews.com ... automotive news. Co-anchors Bridget Everett and Russell Brown host ...
(Date:5/23/2013)... Springs, FL (PRWEB) May 23, 2013 The ... about redefining retirement. Many Americans are facing a dim life ... the Late Boomers -- those born after 1955 -- carry ... card debt. But all hope for The Golden Years is ... how to reduce debt and keep earning after reaching the ...
(Date:5/23/2013)... that can cause rapidly progressing, life threatening meningitis and ... we have not known how it attaches to the ... it attaches to the airway to colonise", People can ... symptoms, while some people progress to invasive disease. ... of how the bacterium colonises the airway. Now that ...
Breaking Medicine News(10 mins):Health News:Fresh Healthy Vending Receives Recent National and Local Media Focus 2Health News:Fitzpatrick Advertising Founder Brings Auto Industry into Focus with CBT News 2Health News:Viewpoints with Terry Bradshaw Presents a Series on Redefining Retirement 2Health News:New discovery in fight against deadly meningococcal disease 2
... VaniqaT is a prescription drug which was approved by the ... treating excessive facial hair ,in women, which is often part ... alternative for women for whom this problem is considered ... once a ,week for hair removal. Vaniqa is actually ...
... can be regenerated using stem cells from blood -- ... grow their own liver transplants using bone marrow. This adds ... as "master cells" because they can produce a variety of ... create custom-grown organ transplants. , , ,"The liver is an ...
... in Dallas soon report that amphetamines may speed up the ... , ,This study was done on patients who had suffered from ... oxygen to the brain., , ,Amphetamines were given to 30 stroke ... while they don't know for sure until the results are finalized, ...
... symptoms of depression are at an increased risk of stroke, ... Prevention. In particular, depressed African Americans showed the largest ... levels of depression had a 73% increase in their risk ... actually caused the stroke, or if some unknown factor related ...
... the AIDS crisis ravaging sub-Saharan Africa dominates much of the ... and AIDS workers are sounding the alarm for what many ... very serious catastrophe in the offing, and if there's an ... it's not any of the other superpowers--the big threat to ...
... from June issue of the American Journal of Epidemiology ... rates than taller people from most causes except cancer. ... women undertaken by Dr.Pekka Jousilahti and his colleagues from ... was found that there was an association between adult ...
Cached Medicine News:
(Date:5/23/2013)... MILFORD, Mass. , May 23, 2013  Spring ... for the treatment of viral infections, today announced that ... of SB 9200, its investigational, once daily, oral therapy ... conducted in healthy, HCV-infected patients and is designed to ... 9200. SB 9200 is a first-in-class drug for the ...
(Date:5/23/2013)... , May 23, 2013   Direct to ... mastectomy is an appropriate option for many women ... surgically reduce their breast cancer risk, or with ... expansion process and a second surgery to insert ... the same surgery as mastectomy can be a ...
(Date:5/23/2013)... BALTIMORE , May 23, 2013  Ameritox, ... been selected by Progressive Medical, Inc. to become ... to help clients manage pharmacy costs and improve ... Progressive Medical, a leading pharmacy benefit manager in ... its overall medication compliance and pain management strategy ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 2Direct to Implant ("One Step") Mastectomy Breast Reconstruction Reduces Number of Surgeries and Time to Final Cosmetic Results 3Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 2Ameritox Joins with Progressive Medical in Urine Drug Monitoring Network to Help Improve Care of Injured Workers 3
... Australia, Aug. 31 What and When Data ... poster,format at worldsleep07: The 5th World Congress of the World ... in Cairns, Australia,September 2-6, 2007. This large clinical study demonstrated ... up to six months versus,placebo in adult patients with chronic ...
... Aug. 31 Oncology,focused pharmaceutical development company ... completed a Phase II clinical trial evaluating ... cancer cells from an,autologous graft in bone ... from the clinical study revealed improved overall ...
Cached Medicine Technology:New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 2New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia 3Kiadis Pharma Announces Promising Phase II Clinical Trial Results for Reviroc 2
The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success....
... The integration of Trabecular Metal ... implant design results in a fusion ... only meets surgeon demands for initial ... a wide variety of shell and ...
The Trilogy system builds on the success of the Harris/Galante Porous and HGP II cups by combining proven features with new technology designed to inhibit the formation and migration of polyethylene ...
For primary and revision cases...
Medicine Products: